BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18287853)

  • 1. Uptake of Tc-99m methylene diphosphonate in peritoneal metastases from breast cancer.
    Wong WY; Wong JS
    Clin Nucl Med; 2008 Mar; 33(3):218-9. PubMed ID: 18287853
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningioma detected incidentally on early Tc-99m MDP whole-body imaging during a workup for breast cancer.
    Cheng TF; Chen YK; Kao CH
    Clin Nucl Med; 2005 Jan; 30(1):37-8. PubMed ID: 15604969
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical uptake of 99m Tc-HMDP in a patient with metastatic liver disease.
    Moya Espinosa P; Amrani Raissouni T; Ramos Moreno E; Martínez del Valle Torres MD; Ortega Lozano SJ; Jiménez-Hoyuela García JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):350-1. PubMed ID: 23169390
    [No Abstract]   [Full Text] [Related]  

  • 4. Accumulation of Tc-99m MDP by omental tumor in metastatic cecal cancer.
    Rutherford GC; Green DJ; O'Connor AR
    Clin Nucl Med; 2006 Oct; 31(10):655-7. PubMed ID: 16985381
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe systemic reaction to (99m)Tc-methylene diphosphonate: a case report.
    Balan KK; Choudhary AK; Balan A; Wishart G
    J Nucl Med Technol; 2003 Jun; 31(2):76-8. PubMed ID: 12777457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental thyroid Tc-99m methylene diphosphonate (MDP) uptake in a patient affected by polynodular goiter at bone scintigraphy.
    Bertagna F; Bosio G; Giubbini R
    Nucl Med Rev Cent East Eur; 2009; 12(2):81-2. PubMed ID: 20235059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ga-67 citrate and Tc-99m MDP uptake in peritoneal metastases from a poorly differentiated adenocarcinoma of gynecologic origin.
    Bykov S; Garty I
    Clin Nucl Med; 1997 May; 22(5):342-3. PubMed ID: 9152547
    [No Abstract]   [Full Text] [Related]  

  • 8. SPECT-CT finding of (99m)Tc-HMDP uptake in abdominal adenopathies in a patient with metastasic breast cancer.
    García-Talavera P; Ruiz MA; González-Selma ML; Sainz-Esteban A; Cobo A; Villanueva JG; Gamazo C; Olmos R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(3):203-4. PubMed ID: 25103143
    [No Abstract]   [Full Text] [Related]  

  • 9. Extraosseous uptake of Tc-99m methylene diphosphonate in the pectoralis muscles 8 days after exercise.
    Groell R; Aigner R
    Clin Nucl Med; 2000 Jan; 25(1):65-6. PubMed ID: 10634541
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased uptake of technetium-99m methylene diphosphonate in muscles in the course of polymyositis.
    Niemir Z; Oleksa R; Czepczyński R; Sowiński J
    Nucl Med Rev Cent East Eur; 2005; 8(2):153-4. PubMed ID: 16437405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetrically increased uptake in upper extremities on (99m)Tc-MDP bone scintigraphy caused by intra-arterial injection: different uptake patterns in three cases.
    Ceylan Gunay E; Erdogan A
    Rev Esp Med Nucl; 2011; 30(6):372-5. PubMed ID: 21440333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal carcinomatosis from ruptured hepatocellular carcinoma on bone scintigraphy.
    Gi MT; Ho YY
    Clin Nucl Med; 2005 Nov; 30(11):744-6. PubMed ID: 16237302
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple brown tumors with Tc-99m MDP superscan appearance and negative Tc-99m MIBI uptake.
    Zanglis A; Andreopoulos D; Zissimopoulos A; Baziotis N
    Clin Nucl Med; 2006 Oct; 31(10):640-3. PubMed ID: 16985376
    [No Abstract]   [Full Text] [Related]  

  • 14. Adult metastatic pancreaticoblastoma detected with Tc-99m MDP bone scan.
    Kuxhaus L; Swayne LC; Chevinsky A; Samli B
    Clin Nucl Med; 2005 Aug; 30(8):577-8. PubMed ID: 16024962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDP uptake in peritoneal carcinomatosis and Krukenberg tumors from mucinous adenocarcinoma.
    Oppenheimer AG; Onyedika C; Freeman LM
    Clin Nucl Med; 2011 Mar; 36(3):235-6. PubMed ID: 21285688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of scintimammography with tc-99m MIBI in clinical practice.
    Filippi L; Pulcini A; Remediani S; Masci E; Redler A; Scopinaro F; De Vincentis G
    Clin Nucl Med; 2006 Dec; 31(12):761-3. PubMed ID: 17117069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed epiphyseal closure seen on Tc-99m methylene disphosphonate bone scan in association with hypopituitarism.
    Artal D; Rosenberg RJ; Cronin EB
    Clin Nucl Med; 2009 May; 34(5):310-1. PubMed ID: 19387213
    [No Abstract]   [Full Text] [Related]  

  • 18. Tc-99m HMDP accumulation in primary peritoneal mesothelioma.
    González-Reimers E; Gomez MA; Santolaria-Fernandez F; Cruz-Diaz M; Alvarez-Argüelles H
    Clin Nucl Med; 1992 Sep; 17(9):738-9. PubMed ID: 1395350
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased renal uptake of technetium-99m HEDP in a patient with breast cancer.
    Chuah JH; Loughran CF
    Br J Radiol; 2010 Jan; 83(985):82-4. PubMed ID: 20139250
    [No Abstract]   [Full Text] [Related]  

  • 20. Does radioiodine treatment change the methylene diphosphonate uptake in a toxic thyroid nodule on bone scintigraphy?
    Mulazimoglu M; Karyagar S; Saglampinar S; Ozpacaci T
    Clin Nucl Med; 2008 Oct; 33(10):731-3. PubMed ID: 18806586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.